• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症免疫学与人类乳头瘤病毒

Cancer Immunology and HPV.

作者信息

Wollenberg Barbara

机构信息

Department of Otorhinolaryngology, University of Schleswig-Holstein Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.

出版信息

Recent Results Cancer Res. 2017;206:243-248. doi: 10.1007/978-3-319-43580-0_19.

DOI:10.1007/978-3-319-43580-0_19
PMID:27699544
Abstract

HNSCC is a heterogeneous group of tumors located in the oral cavity, oropharynx, hypopharynx and larynx. Originally, tobacco and alcohol exposures were the main risk factors for HNSCC. In the last two decades, HPV infections have been identified as a risk factor for HNSCC, especially for oropharyngeal tumors. Whereas the HPV-induced oropharyngeal carcinomas predominantly express the HPV16 related E6 and E7 oncoproteins, the HPV-negative HNSCC are associated with an overexpression of p53. However, if the therapy successes for HPV-negative and HPV-positive HNSCCs are compared, there are significantly higher total survival rates for HPV-positive oropharyngeal tumors compared to HPV-negative tumors. It is important to understand this phenomenon in order to improve and adapt therapy concepts.

摘要

头颈部鳞状细胞癌(HNSCC)是一组异质性肿瘤,位于口腔、口咽、下咽和喉部。最初,烟草和酒精暴露是HNSCC的主要危险因素。在过去二十年中,人乳头瘤病毒(HPV)感染已被确定为HNSCC的一个危险因素,尤其是口咽肿瘤。HPV诱导的口咽癌主要表达与HPV16相关的E6和E7癌蛋白,而HPV阴性的HNSCC与p53的过表达有关。然而,如果比较HPV阴性和HPV阳性HNSCC的治疗成功率,HPV阳性口咽肿瘤的总生存率明显高于HPV阴性肿瘤。了解这一现象对于改进和调整治疗方案很重要。

相似文献

1
Cancer Immunology and HPV.癌症免疫学与人类乳头瘤病毒
Recent Results Cancer Res. 2017;206:243-248. doi: 10.1007/978-3-319-43580-0_19.
2
Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.包含或缺乏转录活性人乳头瘤病毒的头颈癌中的遗传模式
J Natl Cancer Inst. 2004 Jul 7;96(13):998-1006. doi: 10.1093/jnci/djh183.
3
Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.人乳头瘤病毒(HPV)16 与 HPV 感染低流行地区头颈部癌症的预后。
Cancer Causes Control. 2014 Apr;25(4):461-71. doi: 10.1007/s10552-014-0348-8. Epub 2014 Jan 29.
4
Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.经典风险因素而非人乳头瘤病毒(HPV)状态可预测晚期头颈癌患者放化疗后的生存率。
J Cancer Res Clin Oncol. 2016 Oct;142(10):2185-96. doi: 10.1007/s00432-016-2203-7. Epub 2016 Jul 1.
5
Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer.头颈部癌症患者的全身性和局部性人乳头瘤病毒 16 特异性 T 细胞免疫。
Int J Cancer. 2012 Jul 15;131(2):E74-85. doi: 10.1002/ijc.26497. Epub 2011 Nov 19.
6
HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequence.人乳头瘤病毒在头颈部鳞状细胞癌中的整合:原因与后果
Recent Results Cancer Res. 2017;206:57-72. doi: 10.1007/978-3-319-43580-0_4.
7
Prevalence of human papillomavirus types, viral load and physical status of HPV16 in head and neck squamous cell carcinoma from the South Swedish Health Care Region.瑞典南部医疗保健地区头颈部鳞状细胞癌中人乳头瘤病毒类型的流行情况、病毒载量及HPV16的实际状况
J Gen Virol. 2016 Nov;97(11):2949-2956. doi: 10.1099/jgv.0.000611. Epub 2016 Sep 21.
8
TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.TRAF3/CYLD突变可鉴定出人类乳头瘤病毒相关头颈部鳞状细胞癌的一个独特亚群。
Cancer. 2017 May 15;123(10):1778-1790. doi: 10.1002/cncr.30570. Epub 2017 Mar 13.
9
Human papillomavirus-positive tonsillar carcinomas: a different tumor entity?人乳头瘤病毒阳性扁桃体癌:一种不同的肿瘤实体?
Med Microbiol Immunol. 2003 Aug;192(3):129-32. doi: 10.1007/s00430-002-0126-1. Epub 2002 Sep 14.
10
Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.人乳头瘤病毒相关的头颈部鳞状细胞癌生存率:按肿瘤部位和初始治疗方法进行的比较
Head Neck Pathol. 2014 Mar;8(1):77-87. doi: 10.1007/s12105-013-0486-4. Epub 2013 Sep 4.

引用本文的文献

1
Role of HPV status and PD-L1 expression in prognosis of laryngeal squamous cell carcinoma.人乳头瘤病毒(HPV)状态和程序性死亡受体配体1(PD-L1)表达在喉鳞状细胞癌预后中的作用
Int J Clin Exp Pathol. 2021 Jan 1;14(1):107-115. eCollection 2021.
2
The effects and safety of PD-1/PD-L1 inhibitors on head and neck cancer: A systematic review and meta-analysis.PD-1/PD-L1 抑制剂对头颈部癌症的疗效和安全性:系统评价和荟萃分析。
Cancer Med. 2019 Oct;8(13):5969-5978. doi: 10.1002/cam4.2510. Epub 2019 Aug 22.
3
Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma.
头颈部鳞状细胞癌中程序性死亡配体 1 表达、CD8+肿瘤浸润淋巴细胞和 p16 状态的特征和影响。
Med Oncol. 2019 Jan 21;36(2):21. doi: 10.1007/s12032-018-1241-1.